Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:19
Arrowhead Pharmaceuticals Price to Book Value : 26.30 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 26.41 |
| August 20, 2026 | 26.52 |
| August 19, 2026 | 27.11 |
| August 18, 2026 | 26.65 |
| August 17, 2026 | 26.89 |
| August 14, 2026 | 26.27 |
| August 13, 2026 | 25.95 |
| August 12, 2026 | 26.45 |
| August 11, 2026 | 27.06 |
| August 10, 2026 | 26.78 |
| August 07, 2026 | 26.57 |
| August 06, 2026 | 26.02 |
| August 05, 2026 | 26.35 |
| August 04, 2026 | 27.16 |
| August 03, 2026 | 26.08 |
| July 31, 2026 | 25.66 |
| July 30, 2026 | 26.47 |
| July 29, 2026 | 26.14 |
| July 28, 2026 | 26.01 |
| July 27, 2026 | 25.93 |
| July 24, 2026 | 25.95 |
| July 23, 2026 | 26.31 |
| July 22, 2026 | 26.89 |
| July 21, 2026 | 22.59 |
| July 20, 2026 | 21.72 |
| Date | Value |
|---|---|
| July 17, 2026 | 22.53 |
| July 16, 2026 | 21.64 |
| July 15, 2026 | 21.77 |
| July 14, 2026 | 21.80 |
| July 13, 2026 | 22.47 |
| July 10, 2026 | 23.16 |
| July 09, 2026 | 25.47 |
| July 08, 2026 | 25.99 |
| July 07, 2026 | 26.37 |
| July 06, 2026 | 26.24 |
| July 02, 2026 | 25.46 |
| July 01, 2026 | 24.39 |
| June 30, 2026 | 24.71 |
| June 29, 2026 | 18.43 |
| June 26, 2026 | 18.06 |
| June 25, 2026 | 18.15 |
| June 24, 2026 | 18.27 |
| June 23, 2026 | 18.29 |
| June 22, 2026 | 18.77 |
| June 18, 2026 | 18.73 |
| June 17, 2026 | 18.55 |
| June 16, 2026 | 17.53 |
| June 15, 2026 | 17.66 |
| June 12, 2026 | 17.06 |
| June 11, 2026 | 17.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.253 |
| Intellia Therapeutics, Inc. | 2.415 |
| Denali Therapeutics, Inc. | 4.629 |
| Twist Bioscience Corp. | 19.79 |
| Revolution Medicines, Inc. | 17.39 |
Price to Book Value Related Metrics
| PS Ratio | 18.21 |
| PEG Ratio | -0.4987 |
| Price | 86.74 |
| Earnings Yield | -2.59% |
| Market Cap | 12.24B |
| PEGY Ratio | -0.4987 |